Colorectal Cancer (CRC) Completed Phase 1 Trials for Panitumumab (DB01269)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03428958	A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fosifloxuridine nafalbenamide (DB14859) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526) Panitumumab (DB01269)
NCT03263429	Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer	Treatment	Irinotecan (DB00762) Panitumumab (DB01269) Telaglenastat (DB15232)
NCT00788957	Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)	Treatment	Ganitumab (DB12205) Panitumumab (DB01269) Rilotumumab (DB11972)
NCT00867334	New Individualized Therapy Trial for Metastatic Colorectal Cancer	Treatment	Imatinib (DB00619) Panitumumab (DB01269)
NCT00630786	Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study	Treatment	Conatumumab (DB11646) Panitumumab (DB01269)
NCT01139138	Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer	Treatment	Everolimus (DB01590) Irinotecan (DB00762) Panitumumab (DB01269)
NCT02613221	A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer	Treatment	Panitumumab (DB01269) Tipiracil (DB09343)
NCT02008383	Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer	Treatment	Cabozantinib (DB08875) Panitumumab (DB01269)
NCT00879385	KRAS Wild-type Metastatic Colorectal Cancer Trial	Treatment	Decitabine (DB01262) Panitumumab (DB01269)
NCT00004879	Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer	Treatment	Panitumumab (DB01269)